These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20399810)

  • 1. Susceptibility of Plasmodium falciparum to glutamate dehydrogenase inhibitors--a possible new antimalarial target.
    Aparicio IM; Marín-Menéndez A; Bell A; Engel PC
    Mol Biochem Parasitol; 2010 Aug; 172(2):152-5. PubMed ID: 20399810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
    Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
    Naughton JA; Nasizadeh S; Bell A
    Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
    Jung SY; Zheng B; Choi YY; Soh BY; Kim SY; Park KI; Park H
    Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of Plasmodium falciparum glutamate dehydrogenase, a putative target for novel antimalarial drugs.
    Werner C; Stubbs MT; Krauth-Siegel RL; Klebe G
    J Mol Biol; 2005 Jun; 349(3):597-607. PubMed ID: 15878595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
    Yanow SK; Purcell LA; Spithill TW
    Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of Plasmepsin II-potential antimalarial agents.
    Corminboeuf O; Dunet G; Hafsi M; Grimont J; Grisostomi C; Meyer S; Binkert C; Bur D; Jones A; Prade L; Brun R; Boss C
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6194-9. PubMed ID: 17000102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin.
    Kumar R; Musiyenko A; Barik S
    Mol Biochem Parasitol; 2005 May; 141(1):29-37. PubMed ID: 15811524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. That was then but this is now: malaria research in the time of an eradication agenda.
    Kappe SH; Vaughan AM; Boddey JA; Cowman AF
    Science; 2010 May; 328(5980):862-6. PubMed ID: 20466924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.
    Chen X; Chong CR; Shi L; Yoshimoto T; Sullivan DJ; Liu JO
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14548-53. PubMed ID: 16983082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro cultivation of Plasmodium falciparum. Applications and limits.- Methodology].
    Druilhe P; Gentilini M
    Med Trop (Mars); 1982; 42(4):437-62. PubMed ID: 6755144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
    Nallan L; Bauer KD; Bendale P; Rivas K; Yokoyama K; Hornéy CP; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Hamilton A; Sebti S; Windsor WT; Weber PC; Buckner FS; Chakrabarti D; Gelb MH; Van Voorhis WC
    J Med Chem; 2005 Jun; 48(11):3704-13. PubMed ID: 15916422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of the antimalarial microtubule inhibitors trifluralin and vinblastine by Plasmodium falciparum.
    Naughton JA; Hughes R; Bray P; Bell A
    Biochem Pharmacol; 2008 Apr; 75(8):1580-7. PubMed ID: 18291349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new antimalarial leads by use of virtual screening against cytochrome bc₁.
    Rodrigues T; Moreira R; Gut J; Rosenthal PJ; O Neill PM; Biagini GA; Lopes F; dos Santos DJ; Guedes RC
    Bioorg Med Chem; 2011 Nov; 19(21):6302-8. PubMed ID: 21958736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes.
    Akaki M; Nakano Y; Ito Y; Nagayasu E; Aikawa M
    Parasitol Res; 2002 Dec; 88(12):1044-50. PubMed ID: 12444453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the redox metabolism of Plasmodium falciparum.
    Nepveu F; Turrini F
    Future Med Chem; 2013 Oct; 5(16):1993-2006. PubMed ID: 24175748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.